NIDA Research Monograph, Number 92 [Printed in 1989]
If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able
to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.
This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.
Download Monograph92.pdf - Testing for Abuse Liability of Drugs in Humans (2.2 MB)
Table of Contents
Introduction
Testing and Abuse Liability of Drugs in Humans-----1
Charles R. Schuster
The Necessity and Utility of Abuse Liability Evaluations in Human Subjects: The FDA Perspective-----7
Frank J. Vocci, Jr
The Role of Abuse Liability Testing in Drug Control Procedures-----21
Howard McClain, Jr. and Frank Sapienza
Historical Perspectives on the Use of Subjective Effects Measures in Assessing the Abuse Potential of Drugs-----43
Jerome H. Jaffe and Faith K. Jaffe
Drug Identification and Classification
Human Abuse Liability Assessment by Measurement of Subjective and Physiological Effects-----73
Donald R. Jasinski and Jack E. Henningfield
Drug Discrimination: Methods for Drug Characterization and Classification-----101
George E. Bigelow and Kenzie L. Preston
Assessment of the Reinforcing Properties
Abuse Liability of Anxiolytics and Sedative/Hypnotics: Methods Assessing the Likelihood of Abuse-----123
John D. Roache and Roland R. Griffiths
Drug Self-Administration Procedures: Alcohol and Marijuana-----147
Nancy K. Mello
The Use of Choice Procedures for Assessing the Reinforcing Properties of Drugs in Humans-----171
Chris E. Johanson and Harriet de Wit
Relationship Between Self-Reported Drug Effects and Their Reinforcing Effects: Studies with Stimulant Drugs-----211
Marian W. Fischman
Epidemiologic Assessment of Drug Abuse of Drugs
Case Reports and the Assessment of Drug Abuse Liability-----231
Edward C. Senay
United States Epidemiologic Data on Drug Use and Abuse: How are They Relevant to Testing Abuse Liability of Drugs?-----241
James C. Anthony and Alison M. Trinkoff
Current Approaches to Measurements of Drug Use and Abuse in Sweden-----267
Ulf Bergman and David Lee
Evaluation of the Abuse Liability of Drugs in Humans: Issues and Future Directions
Pharmacokinetic and Phartnacodynamic Drug Interactions: Implications for Abuse Liability Testing-----287
Edward M. Sellers, Usanda Busto, and Howard L. Kaplan
Promising New Biologic and Behavioral Correlates of the Reinforcing Properties of Drugs-----307
Jack H. Mendelson, Nancy K. Mello, Scott E. Lukas, Bryan T. Woods, and Siew K. Teoh
Drug Abuse Liability Testing: Human Subject Issues-----341
Herbert D. Kleber
Issues in Human Drug Abuse Liability Testing: Overview and Prospects for the Future-----357
Joseph V. Brady
Conference Summary and Perspectives on Human Drug Abuse Liability Testing-----371
Mary Jeanne Kreek
Index-----377
List of NIDA Research Monographs-----393
|
